Home › Melanoma › North Carolina › Durham
Pag-aaral pangklinika para sa Melanoma sa Durham, NC
Isang pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Durham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Durham VA Medical Center, Durham
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
Nagre-recruitPhase 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Nagre-recruitPhase 3
- Duke Health System, Durham
DESTINY-PANTUMOUR04
Nagre-recruitObservasyonal na pag-aaral
- Research Site, Durham
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Nagre-recruitPhase 3
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Nagre-recruitPhase 2
- Local Institution - 0100, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Nagre-recruitObservasyonal na pag-aaral
- UNC- Chapel Hill, Chapel Hill · 10 mi ang layo
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
Nagre-recruitPhase 1/2
- University of North Carolina, Chapel Hill · 10 mi ang layo
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Nagre-recruitPhase 1/2
- Duke Cancer Institute, Durham
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Nagre-recruitPhase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
Nagre-recruitPhase 1
- Duke University Medical Center, Durham
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
Nagre-recruitPhase 1/2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Nagre-recruitPhase 1/2
- Duke University Medical Center, Durham
IL-17 Blockade to Decrease irAEs (REPLAY)
Nagre-recruitPhase 1
- Duke University Health System, Durham
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Nagre-recruitPhase 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Nagre-recruitPhase 2/3
- Duke University Medical Center, Durham
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Nagre-recruitPhase 3
- Duke University Medical Center - Duke Cancer Center, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi ang layo
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
Nagre-recruit
- Duke University Health System, Durham
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Nagre-recruit
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · 13 mi ang layo
Pag-aaral para sa Melanoma sa ibang lungsod
- Houston, TX59 pag-aaral
- New York City, NY38 pag-aaral
- Los Angeles, CA34 pag-aaral
- Nashville, TN33 pag-aaral
- Pittsburgh, PA31 pag-aaral
- Boston, MA26 pag-aaral
- Philadelphia, PA23 pag-aaral
- San Francisco, CA22 pag-aaral
- Columbus, OH21 pag-aaral
- Atlanta, GA21 pag-aaral
- Salt Lake City, UT21 pag-aaral
- St. Louis, MO21 pag-aaral
Iba pang pag-aaral sa Durham
- Kanser sa Suso64 pag-aaral
- Kanser (lahat ng uri)58 pag-aaral
- Non-Small Cell Lung Cancer39 pag-aaral
- Multiple Myeloma37 pag-aaral
- Acute Myeloid Leukemia33 pag-aaral
- Metastatic Cancer33 pag-aaral
- Kanser sa Prostate32 pag-aaral
- Kanser sa Baga32 pag-aaral
- Colorectal Cancer28 pag-aaral
- Kanser sa Ovary27 pag-aaral
- Chronic Lymphocytic Leukemia27 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.